siRNA treatment reduces triglycerides in people with unusual condition

.INVESTIGATION FEATURE.19 September 2024.

Plozasiran lowered triglyceride amounts through 80% and also decreased the danger of pancreatitis in clients with persistent chylomicronemia, along with or without a hereditary prognosis.